University of Minnesota. Driven to Discover.
Other new reports detail co-infections with other mosquito-borne viruses and fatal encephalitis.
The WHO's mosquito-control assessment spoke to the complex and daunting task, but also acknowledged a possible role for newer tools.
Also, Brazil's health ministry rejected a possible microcephaly link to larvicides, and experts are gathering for a US Zika priority workshop tomorrow.
The WHO's top drug and development official projected the launch of a large vaccine trial is still at least 18 months away, but a test might be available within weeks.
Seven outbreak countries are seeing a rise in microcephaly or Guillain-Barre disease.
Today's emergency declaration was tailored to spur coordinated international study into the possible serious complications of the disease.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.